Kevin’s 20-year career has focused on developing marketing and commercial strategies for new or in-line brands for medical device, diagnostics and pharmaceutical manufacturers. Prior to joining, Kevin was with IQVIA, ZS Associates, Deloitte, and Rosetta Consulting, working on sales and marketing engagements across the U.S., Europe and Asia. Kevin has deep experience in early commercialization strategy, launch planning, patient/customer journey, go-to-market/commercialization strategy and execution, product/portfolio positioning, and value proposition development in a variety of different therapeutic areas for life sciences clients

Kevin has worked across all sectors of the healthcare space, including with hospitals/providers, pharmaceuticals, MedTech and diagnostics manufacturers, and the FDA. Kevin has expertise in imaging and diagnostics, cardiovascular and endovascular devices, GI, women’s health, men’s health, diabetes, intensive care, neurology, ENT and orthopedics.

Kevin holds an AB from Harvard University and an MBA from William and Mary, Mason School of Business.